MONTREAL, QUEBEC--(Marketwire - June 19, 2012) - Biotonix (2010) Inc. ("Biotonix" or the "Company") (TSX VENTURE:BTX) is pleased to announce that it has filed a preliminary prospectus for a new issue of units of the Company (the "Units") at a price of $0.30 per Unit for a minimum of $1,500,000 and a maximum of $2,500,000 in the province of Québec (the "Offering"). Each Unit is comprised of one common share and one half of one common share purchase warrant (a "Warrant") of the Company, taking into account a proposed consolidation of shares on the basis of one new share (a "Consolidated Share") for each two shares outstanding. Each full Warrant entitles its holder to purchase one Consolidated Share of the Company at a price of $0.60 per share for a period of 24 months from the closing date of the Offering.
The Offering will be conducted on a "best effort" agency basis through Industrial Alliance Securities Inc. (the "Agent"). The Company will agree to pay the Agent a 9% cash commission and grant compensation options to the Agent entitling it to purchase that number of Consolidated Shares of the Company equal to 9% of the aggregate number of Units issued and sold under the Offering.
The Offering is made in connection with the reverse takeover of the Company by 9130-4519 Quebec Inc. ("Atman") (see press releases dated December 22, 2011 and February 27, 2012) and is conditional upon the closing of such transaction. The proceeds from the Offering will be used primarily for market development, sales, marketing, distribution and evaluation of acquisition targets of the entity which will result from the reverse takeover ("AtmanCo"). The balance of the proceeds will be used for AtmanCo's working capital.
The Offering is subject to customary conditions and the approval of the Autorité des marchés financiers and the TSX Venture Exchange.
BIOTONIX PROFILE
Biotonix (TSX VENTURE:BTX) offers innovative health solutions for posture correction and fitness using a web-based imaging software technology. For more information please visit www.biotonix.com.
ATMAN PROFILE
Atman provides 6th generation psychometric testing solutions to enterprises seeking to maximize success in employee recruitment, job allocation and team building by scientifically matching each individual's character and talents to specific company needs. For more information please visit www.atmanco.com.
BIOTONIX'S FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While Biotonix anticipates that subsequent events and developments may cause its views to change, Biotonix specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
Louise St-Onge
CEO
514.840.0004 ext 229
www.biotonix.com